Neuroinflammation in Parkinson’s disease – putative pathomechanisms and targets for disease-modification
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Frontiers in Immunology (2022) 13:878771. DOI:10.3389/fimmu.2022.878771
- Event
-
Veröffentlichung
- (where)
-
Würzburg
- (who)
-
Universität Würzburg
- (when)
-
2023
- Creator
-
Grotemeyer, Alexander
McFleder, Rhonda Leah
Wu, Jingjing
Wischhusen, Jörg
Ip, Chi Wang
- DOI
-
10.3389/fimmu.2022.878771
- URN
-
urn:nbn:de:bvb:20-opus-274665
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:55 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Grotemeyer, Alexander
- McFleder, Rhonda Leah
- Wu, Jingjing
- Wischhusen, Jörg
- Ip, Chi Wang
- Universität Würzburg
Time of origin
- 2023
Other Objects (12)
Glycosphingolipids and neuroinflammation in Parkinson’s disease
Neuroinflammation and protein pathology in Parkinson’s disease dementia
Modeling Neuroinflammation in sporadic Parkinson ́s disease
LRRK2 and neuroinflammation: partners in crime in Parkinson’s disease?
Neurodegeneration and Neuroinflammation in Parkinson’s Disease: a Self-Sustained Loop
NLRP3 Inflammasome-Mediated Neuroinflammation and Related Mitochondrial Impairment in Parkinson’s Disease
CXCL12 is involved in α-synuclein-triggered neuroinflammation of Parkinson’s disease
The role of Toll-like receptors and neuroinflammation in Parkinson’s disease
Universal clinical Parkinson’s disease axes identify a major influence of neuroinflammation
Prodromal Parkinson's disease: hype or hope for disease-modification trials?
Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease
Nutraceuticals in Parkinson’s Disease
Glycosphingolipids and neuroinflammation in Parkinson’s disease
Neuroinflammation and protein pathology in Parkinson’s disease dementia
Modeling Neuroinflammation in sporadic Parkinson ́s disease
LRRK2 and neuroinflammation: partners in crime in Parkinson’s disease?
Neurodegeneration and Neuroinflammation in Parkinson’s Disease: a Self-Sustained Loop
NLRP3 Inflammasome-Mediated Neuroinflammation and Related Mitochondrial Impairment in Parkinson’s Disease
CXCL12 is involved in α-synuclein-triggered neuroinflammation of Parkinson’s disease
The role of Toll-like receptors and neuroinflammation in Parkinson’s disease
Universal clinical Parkinson’s disease axes identify a major influence of neuroinflammation
Prodromal Parkinson's disease: hype or hope for disease-modification trials?
Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease
Nutraceuticals in Parkinson’s Disease
Glycosphingolipids and neuroinflammation in Parkinson’s disease
Neuroinflammation and protein pathology in Parkinson’s disease dementia
Modeling Neuroinflammation in sporadic Parkinson ́s disease
LRRK2 and neuroinflammation: partners in crime in Parkinson’s disease?
Neurodegeneration and Neuroinflammation in Parkinson’s Disease: a Self-Sustained Loop
NLRP3 Inflammasome-Mediated Neuroinflammation and Related Mitochondrial Impairment in Parkinson’s Disease
CXCL12 is involved in α-synuclein-triggered neuroinflammation of Parkinson’s disease
The role of Toll-like receptors and neuroinflammation in Parkinson’s disease
Universal clinical Parkinson’s disease axes identify a major influence of neuroinflammation
Prodromal Parkinson's disease: hype or hope for disease-modification trials?
Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease